MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 29 filers reported holding MERSANA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $736,332 | -84.9% | 579,789 | -60.8% | 0.00% | – |
| Q2 2023 | $4,867,545 | +378.3% | 1,479,497 | +497.5% | 0.00% | – |
| Q1 2023 | $1,017,760 | +40.8% | 247,630 | +100.7% | 0.00% | – |
| Q4 2022 | $722,990 | -50.4% | 123,377 | -42.8% | 0.00% | – |
| Q3 2022 | $1,458,000 | +155.8% | 215,721 | +74.8% | 0.00% | – |
| Q2 2022 | $570,000 | +12.9% | 123,379 | -2.6% | 0.00% | – |
| Q1 2022 | $505,000 | -33.3% | 126,703 | +4.1% | 0.00% | – |
| Q4 2021 | $757,000 | -66.3% | 121,687 | -48.9% | 0.00% | – |
| Q3 2021 | $2,245,000 | -56.5% | 238,034 | -37.4% | 0.00% | – |
| Q2 2021 | $5,161,000 | -56.2% | 380,029 | -47.9% | 0.00% | -100.0% |
| Q1 2021 | $11,794,000 | -55.0% | 728,929 | -26.0% | 0.00% | -50.0% |
| Q4 2020 | $26,218,000 | +60.3% | 985,255 | +12.2% | 0.00% | 0.0% |
| Q3 2020 | $16,355,000 | -34.4% | 878,329 | -17.5% | 0.00% | -33.3% |
| Q2 2020 | $24,916,000 | +3419.2% | 1,064,788 | +776.9% | 0.00% | – |
| Q1 2020 | $708,000 | -51.8% | 121,423 | -52.6% | 0.00% | – |
| Q4 2019 | $1,469,000 | +261.8% | 256,328 | -0.3% | 0.00% | – |
| Q3 2019 | $406,000 | -61.0% | 257,228 | +0.2% | 0.00% | – |
| Q2 2019 | $1,040,000 | -22.9% | 256,778 | +0.2% | 0.00% | – |
| Q1 2019 | $1,349,000 | +29.1% | 256,328 | 0.0% | 0.00% | – |
| Q4 2018 | $1,045,000 | -59.2% | 256,328 | 0.0% | 0.00% | – |
| Q3 2018 | $2,563,000 | -44.0% | 256,328 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $4,578,000 | +13.2% | 256,328 | -0.1% | 0.00% | – |
| Q1 2018 | $4,045,000 | -7.6% | 256,462 | -3.7% | 0.00% | -100.0% |
| Q4 2017 | $4,377,000 | -85.4% | 266,406 | -84.6% | 0.00% | -75.0% |
| Q3 2017 | $29,999,000 | +25.4% | 1,735,061 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $23,926,000 | – | 1,735,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |